Zhonghua bing li xue za zhi = Chinese journal of pathology
Clinical practice guideline for molecular pathology in colorectal cancer (2025 version)
Abstract
结直肠癌是常见的恶性肿瘤之一，分子病理检测在结直肠癌的精准诊疗中发挥着至关重要的作用。本指南工作组基于近年国内外研究证据，结合多学科专家意见，制定了20条临床实践推荐意见，推荐意见涵盖结直肠癌分子标志物的检测原则、遗传性结直肠癌综合征的基因检测、分子病理实验室质量控制及检测方法等内容。同时，本指南强调临床、病理等多学科沟通与协作。期望推动我国结直肠癌分子病理检测临床应用的规范化，提升结直肠癌精准诊疗水平。.
Source and rights
Published by Zhonghua bing li xue za zhi = Chinese journal of pathology, 2025. The guideline itself is at the source linked here.
Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.
More in oncology
- Non-Small Cell Lung Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In OncologyNational Comprehensive Cancer Network · 2026
- Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HER2+ Breast Cancer in Both the Early and Metastatic Settings (2025 Update)Research Excellence, Active Leadership Canadian Breast Cancer Alliance (REAL Alliance) [2] · 2026
